Tick Talk: The Rise and Spread of Babesiosis in America
A new report from the CDC says that a disease called babesiosis, which is spread by ticks, has become more common in the United States
A new report from the CDC says that a disease called babesiosis, which is spread by ticks, has become more common in the United States
Unlocking the manipulation of mosquitoes by malaria parasites – Female mosquitoes infected with malaria parasites are significantly more attracted to human odour than uninfected mosquitoes. This was demonstrated in a laboratory setting in which infected female Anopheles gambiae sensu stricto mosquitoes were attracted to human odours three times more than mosquitoes that were not infected with the malaria-causing Plasmodium falciparum parasite.
Net advantage — Study finds use of bed nets by 75 percent of population could eradicate malaria – Malaria, the leading cause of death among children in Africa, could be eliminated if three-fourths of the population used insecticide-treated bed nets, according to a new study from the National Institute for Mathematical and Biological Synthesis (NIMBioS).
FDA approves first anti-diarrheal drug for HIV/AIDS patients — Fulyzaq is the second botanical drug approved by the agency – The U.S. Food and Drug Administration approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.
Using cell phone data to curb the spread of malaria — Study in Kenya finds measuring movement of people could lead to more effective ways to control spread of disease – New research that combines cell phone data from 15 million people in Kenya with detailed information on the regional incidence of malaria has revealed, on the largest scale so far, how human travel patterns contribute to the disease’s spread. The findings indicate that malaria, in large part, emanates from Kenya’s Lake Victoria region and spreads east, chiefly toward the capital, Nairobi.
New candidate vaccine neutralizes all tested strains of malaria parasite – A new candidate malaria vaccine with the potential to neutralise all strains of the most deadly species of malaria parasite has been developed by a team led by scientists at the University of Oxford, UK.
Malaria during pregnancy: New study assesses risks during first trimester — Antimalarial drugs safer for pregnant women than disease – The malaria disease significantly increases the risk of miscarriage, but that treating with antimalarial drugs is relatively safe and reduces this risk in pregnant women expecting their new born babies.
Malaria against malaria: A pre-existing malaria infection can prevent a second infection — Study will be published in Nature Medicine this Sunday, May 15, and may have impact in the fight against the disease – A team of researchers have found that pre-existing malaria prevents secondary infection by another Plasmodium strain, the parasite responsible for malaria, by restricting iron availability in the liver of the host.
Researchers identify genes causing antimalarial drug resistance – Using a pair of powerful genome-search techniques, researchers from the Harvard School of Public Health (HSPH), Harvard University, and the Broad Institute have identified several genes that may be implicated in the malaria parasite’s notorious ability to rapidly evade drug treatments.
New antimalarial drug candidate with novel mechanism of action has the potential to rapidly clear a Plasmodium infection upon administration of a single oral dose, as published in Science – Novartis announced that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel compound that shows promise as a next generation treatment for drug resistant malaria.